ARCHIVES

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

February 9, 1990

NCI, IOM Called To Congress to Explain Divergent Positions On Minority Research

January 29, 1999

NCI Cooperative Group, Cancer Center Trials Listed

November 28, 2008

NCI-Approved Clinical Trials

June 30, 2006

NIH establishes new clinical science awards to eventually replace General Clinical Research Centers.

October 21, 2005

Professional Societies: ASCO opposes FDA On Stem Cell Transplant Regs

May 16, 1997